FARALLON CAPITAL MANAGEMENT LLC
Q2 2026 Form 13-F

SAN FRANCISCO, CALIFORNIA
CIK 0000909661 · CRD 107322 · SEC-registered investment adviser
$21.7B Reported Value Total

FARALLON CAPITAL MANAGEMENT, L.L.C. reports 67 total accounts under management (AUM). There are 67 discretionary accounts valued at $52,076,899,000, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Firm Brochure (Part 2A)
Private funds (Form ADV)
71 funds · $65.4B gross asset value
Hedge Fund: $65.4B
Source: Form ADV filed 2026-09-23
Reported value
$21.7B
Quarter over quarter
+23.9%
Holdings
82
Top-10 concentration
62.1%

Filing Structure

Reports holdings for

  • Farallon Capital Europe LLP · File #028-11719 · Q1 2014 – Q4 2024
  • Farallon Capital Europe LLP (not a 13F filer in our records) · Q3 2021 – Q3 2021 · declared by one filing
  • Farallon Capital Europe (not a 13F filer in our records) · Q1 2021 – Q2 2021 · declared by one filing
  • FARALLON PARTNERS L L C/CA (not a 13F filer in our records) · File #028-06372 · Q2 2013 – Q4 2013

Key People

Form ADV owners & control persons
Andrew James Mclean Spokes
LIMITED PARTNER
Richard Pierre Bollini II
MANAGING MEMBER
Colby Trexler Clark
MANAGING MEMBER
Q1 2026

Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.

Loading 13F Metrics

Q2 2026 13F filing summary

Period of report June 30, 2026
Filed August 14, 2026
Form 13F-HR
Reported value $21.7B
Positions 82
Change in reported value +13.7%
New positions 20
Exited positions 104
Position turnover 66.7%
Top-10 concentration 62.1%

13F filings by quarter

Quarter Positions Value
Q2 2026 13F
Filed Aug 14, 2026
 82 $21.7B
Q1 2026 13F
Filed May 15, 2026
 168 $19.1B
Q4 2025 13F
Filed Feb 17, 2026
 148 $23.1B
Q3 2025 13F
Filed Nov 14, 2025
 139 $24.4B
Q2 2025 13F
Filed Aug 14, 2025
 142 $23.8B
Q1 2025 13F
Filed May 15, 2025
 144 $20.9B
Q4 2024 13F
Filed Feb 14, 2025
 145 $22.8B
Q3 2024 13F
Filed Nov 14, 2024
 158 $22.8B
Q2 2024 13F
Filed Aug 14, 2024
 159 $23.3B
Q1 2024 13F
Filed May 15, 2024
 168 $23.6B
Q4 2023 13F
Filed Feb 14, 2024
 148 $21.9B
Q3 2023 13F
Filed Nov 14, 2023
 153 $61.0B
Q2 2023 13F
Filed Aug 14, 2023
 158 $19.9B
Q1 2023 13F
Filed May 15, 2023
 177 $33.5B
Q4 2022 13F
Filed Feb 14, 2023
 226 $16.9B
Q3 2022 13F
Filed Nov 14, 2022
 288 $18.2B
Q2 2022 13F
Filed Aug 15, 2022
 297 $18.4B
Q1 2022 13F
Filed May 16, 2022
 305 $20.7B
Q4 2021 13F
Filed Feb 14, 2022
 292 $20.0B
Q3 2021 13F
Filed Nov 15, 2021
 290 $21.4B

33 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q2 2026

# Holding Reported value % of portfolio
1 SPY P STATE STR SPDR S&P 500 ETF T $4.5B 20.67%
2 RVMD REVOLUTION MEDICINES INC $2.5B 11.71%
3 EA ELECTRONIC ARTS INC $1.6B 7.49%
4 BBIO BRIDGEBIO PHARMA INC $800.1M 3.69%
5 PTGX PROTAGONIST THERAPEUTICS INC $778.2M 3.59%
6 EXEL EXELIXIS INC $732.8M 3.38%
7 LQDA LIQUIDIA CORPORATION $666.9M 3.08%
8 AMZN AMAZON COM INC $627.5M 2.9%
9 LNTH LANTHEUS HLDGS INC $619.4M 2.86%
10 NTRA NATERA INC $602.2M 2.78%
11 UNH UNITEDHEALTH GROUP INC $528.1M 2.44%
12 TMO THERMO FISHER SCIENTIFIC INC $526.0M 2.43%
13 ROIV ROIVANT SCIENCES LTD $506.4M 2.34%
14 AON AON PLC $458.6M 2.12%
15 BSX BOSTON SCIENTIFIC CORP $449.0M 2.07%
16 AVGO BROADCOM INC $435.1M 2.01%
17 MSFT MICROSOFT CORP $415.1M 1.92%
18 TNGX TANGO THERAPEUTICS INC $383.8M 1.77%
19 KKR KKR & CO INC $378.0M 1.74%
20 SNPS SYNOPSYS INC $370.1M 1.71%

Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.

Loading Activities
Loading Sector Allocation
Crunching numbers
Loading Performance
Finding Similar Managers
Finding Potential New Buys
Building table
Loading SEC filing data
Loading Form 4 Filings
Loading 13D/G filings